Teva Pharmaceuticals
TEVA
TEVA
549 hedge funds and large institutions have $13.3B invested in Teva Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 185 increasing their positions, 180 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 538 → 549 (+11)
3% more repeat investments, than reductions
Existing positions increased: 185 | Existing positions reduced: 180
5.56% less ownership
Funds ownership: 62.86% → 57.3% (-5.6%)
Holders
549
Holding in Top 10
27
Calls
$730M
Puts
$428M
Top Buyers
| 1 | +$131M | |
| 2 | +$121M | |
| 3 | +$87.8M | |
| 4 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$75.6M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$70.4M |
Top Sellers
| 1 | -$588M | |
| 2 | -$577M | |
| 3 | -$161M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$81.1M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$70.8M |